Celgene Director HEOR I&I in Summit, New Jersey

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries - and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

The Director of Global HEOR, I&I – Ozanimod is responsible for developing, executing and aligning robust HEOR plans and projects aligned with global strategy and in support of product value proposition, market access and reimbursement. Active leadership in cross-functional teams, strong expertise in HE&OR, significant strategic thinking and communication skills, and the capability to manage multiple projects with minimal oversight is required. Significant interaction with Global partners is required.

Specific responsibilities include:

  • Work with Senior Director HEOR, Access Strategy, Brand and Medical Affairs leaders to understand and embed Ozanimod value proposition in HEOR research and scientific communications plans

  • Interact with Pricing, Affiliates, Advocacy, Publications, Biostatistics, Global Drug Safety, Regulatory, Compliance and others to further ensure transparency and thoughtful, value-add outputs

  • Execute HEOR research in alignment with global strategy, including prospective and retrospective studies, economic models (cost effectiveness, budget impact), comparative effectiveness research, patient-reported outcomes research, systematic literature reviews/meta-analyses, dossiers, etc.

  • Assure timely execution of HEOR projects, and provide timely awareness of results and implications to internal partners as appropriate

  • Represent HEOR Ozanimod at scientific conferences, with customers, and via scientific outputs

  • Generate customer-facing materials and work with internal partners on the channel strategy to communicate the benefits and impact of I&I products

  • Interact with affiliates to share global research and guide local research as appropriate, and to understand and address specific milestones and evidence needs (e.g. HTA resubmissions)

  • Provide HEOR expertise for clinical compounds in development, e.g. assisting in identification and implementation of appropriate PRO instruments to support patient benefits

  • Cultivate awareness of KOLs and other partners to engage in research globally, as appropriate

  • Maintain awareness of the relevant landscape: global HEOR requirements, PRO guidelines, regulatory legislation, clinical guidelines, best practices, and case studies as appropriate

  • Participate in the critical evaluation of strategies and tactics, taking into consideration active and anticipated challenges (e.g. payer/HTA)

  • Provide strong management of budget and vendors

  • Assist in business planning and forecasting / finance exercises

Qualifications:

  • Graduate degree (e.g. MS/MPH or PhD) in a relevant HEOR discipline including health services research, health outcomes research, epidemiology, and pharmacoeconomics; Clinical degree (e.g., in pharmacy, medicine, nursing) is desirable

  • At least 5 years of full-time experience in the life sciences industry conducting HEOR studies and presenting results to internal and external audiences

  • Experience partnering with Marketing, Market Access, and Medical Affairs is required. Experience partnering with Pricing, Country/Regional affiliates, Advocacy, and/or Biostatistics is preferred.

  • Demonstrated knowledge in multiple areas of outcomes research, such as retrospective or prospective studies, patient-reported outcomes/health-related quality of life assessments, economic modeling, literature syntheses/meta-analyses)

  • Track record of research accomplishments including poster/oral presentations at scientific meetings and high quality, peer reviewed publications

  • Strong leadership, strategic thinking, problem solving and decision-making skills

  • Experience influencing strategy internally and successfully collaborating externally (e.g. KOLs)

  • In-depth knowledge of study design, analysis, and interpretation of data

  • Ability to work collaboratively and effectively in a multicultural and cross functional team environment, as well as work independently with limited supervision

  • Strong communication skills - written, verbal and presentation

  • Strong organizational/administrative skills, and ability to manage multiple projects simultaneously

  • Willing to travel, domestically and internationally, approximately 20%

  • Background in immunology area such as MS, IBD or other similar therapeutic area is preferred

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.

Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.

#LI-POST

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.